Hjem › Nevroendokrine tumorer › Utah › Salt Lake City
Kliniske studier for Nevroendokrine tumorer i Salt Lake City, UT
7 studier for Nevroendokrine tumorer søker deltakere på steder i og rundt Salt Lake City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekruttererFase 2/3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RekruttererFase 3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RekruttererFase 1
- Research Facility, Salt Lake City
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Primary Children's Hospital, Salt Lake City
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
RekruttererFase 2
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RekruttererFase 1/2
- Crinetics Study Site, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Salt Lake City
Nevroendokrine tumorer-studier i andre byer
- Philadelphia, PA11 studier
- Washington, DC11 studier
- Rochester, MN9 studier
- Houston, TX8 studier
- Chicago, IL7 studier
- St. Louis, MO7 studier
- Columbus, OH7 studier
- Detroit, MI7 studier
- Cleveland, OH7 studier
- Dallas, TX6 studier
- Charlottesville, VA6 studier
- Miami, FL6 studier
Andre studier i Salt Lake City
- Ikke-småcellet lungekreft31 studier
- Kreft (alle typer)27 studier
- Brystkreft27 studier
- Kolorektal kreft22 studier
- Lungekreft21 studier
- Melanom21 studier
- Multipelt myelom21 studier
- Metastatisk kreft20 studier
- Eggstokkreft19 studier
- Fedme18 studier
- Akut myelogen leukemi17 studier
- Hjertesvikt17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.